Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Strong Closed !! I smell money 💰 💵!!!

<< Previous

Bullboard Posts

Next >>

Comment by porksnifferon Nov 26, 2020 11:00pm

76 Views

Post# 31986797

RE:RE:Strong Closed !! I smell money 💰 💵!!!

MrMugsy wrote: Wonder how much of it was buybacks.

Love how you attem to pass yourself as the board know it all. ZERO was buybacks. There have been ZERO buybacks since Sept. 30. Company is not allowed to buyback shares on the ask (to run up the price) only on the bid. You try and spin everything this company does into a positive lol. Every single share purchased as of this moment has resulted in a LOSS for shareholders FYI.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle